IL43475A - A nonabsorbable,nonnutritive water-soluble flavoring composition and process for preparing the same - Google Patents

A nonabsorbable,nonnutritive water-soluble flavoring composition and process for preparing the same

Info

Publication number
IL43475A
IL43475A IL43475A IL4347573A IL43475A IL 43475 A IL43475 A IL 43475A IL 43475 A IL43475 A IL 43475A IL 4347573 A IL4347573 A IL 4347573A IL 43475 A IL43475 A IL 43475A
Authority
IL
Israel
Prior art keywords
flavoring
agent
composition
controlling means
controlling
Prior art date
Application number
IL43475A
Other versions
IL43475A0 (en
Original Assignee
Dynapol Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US300499A external-priority patent/US3876816A/en
Application filed by Dynapol Corp filed Critical Dynapol Corp
Publication of IL43475A0 publication Critical patent/IL43475A0/en
Publication of IL43475A publication Critical patent/IL43475A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/75—Fixation, conservation, or encapsulation of flavouring agents the flavouring agents being bound to a host by chemical, electrical or like forces, e.g. use of precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Seasonings (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (10)

43475/2 WHAT IS CLAIMED IS: water-soluble^
1. A nonabsorbable, nonnutritive,(flavoring composition comprised of an active flavoring agent covalently , bonded through a position on the active flavoring agent that is nonessential for its flavoring activity, with a covalent bond that maintains its physical and chemical integrity in the gastrointestinal tract to a controlling means that is essentially nonmetabolizable and nonabsorbable, and which controlling means maintains the active flavoring agent within the gastrointestinal tract by substantially restricting passage of the composition through the mucosa of the gastrointestinal tract.
2. The flavoring composition of Claim 1 wherein the controlling means is a hydrophilic water soluble organic polymer having an average molecular weight of from 2,500 to 250,000.
3. The flavoring composition of Claim 2 wherein the organic polymer contains not less than one polar functional group selected from the group consisting of amide, amino, carboxyl, ether and hydroxy1 functional groups the ' \ ;■■ ·■ for each three carbon atoms; resent on/average in the organic polymer. ·" ·'>·· ■■■> ;
4. The flavoring composition of Claim 3 wherein the flavoring agent is. bonded to the controlling means through a nonrupturable nondegradable organic bridge which permits 1 the agent to be at least 5 atoms from the controlling means.
5. The flavoring composition of Claim 3 wherein the active flavoring agent is a sweetening agent and the composition is soluble in water to an amount of not less than 100 ppm. 5
6. The flavoring composition of Claim (£ wherein the sweetening agent comprises an aromatic phenol or an aromatic amine .
7. The process for preparing a nonabsorbable ,Γηοη- nutritive form of a flavoring agent which comprises bonding . said agent through a nonrupturable, nondigestable covalent linkage to a controlling molecule, said controlling molecule being nonmetabolizable and of molecular dimensions which ; control and restrict its movement across the walls of the digestive tract, and thereafter recovering the controlling molecule having agent bonded thereto .
8. The process of Claim 7 wherein the controlling molecule is hydrophilic and has a molecular weight of from 2,500 to 250,000.
9. The process of Claim 8 wherein the flavoring agent is a sweetening agent.
10. The flavoring composition of Claim 1 wherein controlling means is a polymer of molecular weight 2,500 to 250,000, which comprises the active flamonomeric voring agent unit. il. The process of rendering nonnutritive a flavoring agent which comprises joining said flavoring agent by a nonrupturable , nondigestable covalent linkage to a polymeric molecule of molecular weight 2,500 to 250,000, and of molecular dimensions which control and prevent its movement across the walls of the digestive tract. .ttori ey for pp icants
IL43475A 1972-10-25 1973-10-24 A nonabsorbable,nonnutritive water-soluble flavoring composition and process for preparing the same IL43475A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30085772A 1972-10-25 1972-10-25
US300499A US3876816A (en) 1972-10-25 1972-10-25 Nonabsorbable, nonnutritive sweeteners

Publications (2)

Publication Number Publication Date
IL43475A0 IL43475A0 (en) 1974-01-14
IL43475A true IL43475A (en) 1976-04-30

Family

ID=26971813

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43475A IL43475A (en) 1972-10-25 1973-10-24 A nonabsorbable,nonnutritive water-soluble flavoring composition and process for preparing the same

Country Status (10)

Country Link
JP (1) JPS5631944B2 (en)
CA (1) CA1011986A (en)
CH (1) CH591215A5 (en)
DE (1) DE2352905A1 (en)
FR (1) FR2204369B1 (en)
GB (1) GB1423700A (en)
IL (1) IL43475A (en)
IT (1) IT1047950B (en)
NL (1) NL7314587A (en)
SU (1) SU508160A3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390111B1 (en) * 1977-01-21 1988-02-19 Polak Frutal Works PROCESS FOR FIXING FLAVORING ALDEHYDES FOR THEIR APPLICATION IN THE FOOD FIELD
US4448789A (en) * 1982-08-27 1984-05-15 Warner-Lambert Company Enhanced flavor-releasing agent
IT1186782B (en) * 1985-10-18 1987-12-16 Montedison Spa PROCESS FOR THE PREPARATION OF PHENYLPROPANONS
GB0916178D0 (en) * 2009-09-15 2009-10-28 Givaudan Sa Organic compounds

Also Published As

Publication number Publication date
IL43475A0 (en) 1974-01-14
JPS5631944B2 (en) 1981-07-24
SU508160A3 (en) 1976-03-25
JPS49100266A (en) 1974-09-21
CA1011986A (en) 1977-06-14
FR2204369A1 (en) 1974-05-24
AU6144173A (en) 1975-04-17
DE2352905A1 (en) 1974-05-09
NL7314587A (en) 1974-04-29
GB1423700A (en) 1976-02-04
IT1047950B (en) 1980-10-20
FR2204369B1 (en) 1979-10-19
CH591215A5 (en) 1977-09-15

Similar Documents

Publication Publication Date Title
US5219564A (en) Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
JP3053979B2 (en) Multilayer plastic tube
Thacharodi et al. Propranolol hydrochloride release behaviour of crosslinked chitosan membranes
Rutnakornpituk et al. Synthesis, characterization and properties of chitosan modified with poly (ethylene glycol)–polydimethylsiloxane amphiphilic block copolymers
GB929391A (en) Therapeutic compositions comprising polymeric amines
EP0008945A3 (en) Semipermeable composite membrane, process for producing said membrane, and method of desalination using said membrane
US5192617A (en) Transparent liquid absorbent materials
KR910003606A (en) Photopolymerizable recording material
US20110071079A1 (en) Self-assembling poly(diol citrates)-protein hydrogels
DE69917889D1 (en) POLYETHYLENE GLYCOLE DERIVATIVES WITH NEIGHBORING REACTIVE GROUPS
EP0482836A1 (en) Transparent liquid absorbent materials
JP2005525450A5 (en)
JP2007070277A5 (en)
IL149572A0 (en) Film preparation for biphasic release of pharmacologically active or other substances
Nishida et al. Gelation and adhesion behavior of mussel adhesive protein mimetic polymer
IL43475A (en) A nonabsorbable,nonnutritive water-soluble flavoring composition and process for preparing the same
ES2191580T3 (en) HYDROSOLUBBLE OR WATERPROOF POLYMER SALTS.
US10532328B2 (en) Polyaniline-based chlorine resistant hydrophilic filtration membranes
ATE82581T1 (en) WATER SOLUBLE POLYVINYL CARBON ACID BASED ADHESIVE ITS PRODUCTION AND USE.
JPH02149335A (en) Chitosan-gelatine crosslinking gel
Gac et al. Synthesis, characterisation and in vivo behaviour of a norfloxacin-poly (L-lysine citramide imide) conjugate bearing mannosyl residues
JP2002544329A5 (en)
CN108715643B (en) Preparation method of bionic adhesive coating of epoxy and aminophosphorylcholine polymer
GB1402397A (en) Polymers derived from l-lysine
Shen et al. Antiproliferative activity of polymer-bound, monoamine-coordinated platinum complexes against LNCaP human metastatic prostate adenocarcinoma cells